Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy
Condition: Head & Neck Cancer Intervention: Drug: nanoliposomal irinotecan Sponsors: National Health Research Institutes, Taiwan; China Medical University Hospital; Tri-Service General Hospital; Taipei Veterans General Hospital, Taiwan; National Cheng-Kung University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Esophagus Cancer | Hospitals | Nanotechnology | Taiwan Health